CORONIS

Executive Summary

CORONIS is a European Contract Research Organization (CRO) and pharmaceutical consulting firm founded in 2000 and based in Athens, Greece. The company offers end-to-end clinical development, regulatory affairs, real-world evidence, and commercialization services to pharmaceutical, biotech, and medical device companies. With over two decades of experience, CORONIS emphasizes rapid delivery of quality results and a client-centric approach. As a private CRO, it occupies a niche in the European market, leveraging its regulatory and research expertise to support clients through the drug development lifecycle. While not a high-profile player, its established presence and focus on efficiency position it as a reliable partner in the CRO space.

Upcoming Catalysts (preview)

• Q4 2026Expansion of Real-World Evidence Services60% success
• Q2 2026New Strategic Partnership with Mid-Size Pharma50% success
• Q1 2027Launch of Digital Health CRO Capabilities40% success